Sign in

Neurooncology Tuebingen

@neurooncotue.bsky.social
112 followers 116 following 18 posts

Interdiciplinary neurooncologcial activities and research at the Tuebinger university hospital 🧠 @hih-tuebingen.bsky.social 🎓 @unituebingen.bsky.social 🧠 Website: www.hih-tuebingen.de/forschung/neur…

PostsRepliesMedia
Neurooncology Tuebingen @neurooncotue.bsky.social · 22/05/2026
We are very happy to present you our work, recently accepted in Neurooncology! @ghtabatabai.bsky.social @hih-tuebingen.bsky.social academic.oup.com/neuro-oncolo...
academic.oup.com
Molecular modulators of CDK4/6 inhibitor response in experimental glioma identified through genome-wide CRISPR-Cas9 screening
AbstractBackground. Glioblastoma harbors frequent alterations in the retinoblastoma (RB1) pathway, providing a genetic rationale for therapeutic targeting
033
Neurooncology Tuebingen @neurooncotue.bsky.social · 14/11/2025
Now Daniel Merk presents his work at the DGN in Berlin. @dgn-ev.bsky.social @ghtabatabai.bsky.social @hih-tuebingen.bsky.social
020
Reposted by Neurooncology Tuebingen
Hannes Becker @hannes-becker1996.bsky.social · 14/11/2025
Very happy to had the opportunity to present our data at the DGN in Berlin. @ghtabatabai.bsky.social @hih-tuebingen.bsky.social @dgn-ev.bsky.social
022
Neurooncology Tuebingen @neurooncotue.bsky.social · 14/11/2025
We are very happy to present our data at the DGN in Berlin! @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @dgn-ev.bsky.social
031
Neurooncology Tuebingen @neurooncotue.bsky.social · 21/10/2025
We had a wonderful #eano2025 in Prague, with multiple talks and poster presentations and fruitful discussions! Looking forward to Rome! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @nihalolcaydogan.bsky.social @hih-tuebingen.bsky.social
0105
Neurooncology Tuebingen @neurooncotue.bsky.social · 18/10/2025
Now Surender Surender on stage, presenting our data on CDK4/6 inhibition in experimental glioma! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hih-tuebingen.bsky.social
094
Neurooncology Tuebingen @neurooncotue.bsky.social · 18/10/2025
Great talk by @ghtabatabai.bsky.social about time management in academia @eanoassociation.bsky.social
052
Neurooncology Tuebingen @neurooncotue.bsky.social · 17/10/2025
Great poster session with nice discussions about our current work! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @nihalolcaydogan.bsky.social @hih-tuebingen.bsky.social
082
Neurooncology Tuebingen @neurooncotue.bsky.social · 17/10/2025
Nice opportunity to present our data on regorafenib in combination with navitoclax at @eanoassociation.bsky.social @hannes-becker1996.bsky.social @ghtabatabai.bsky.social
032
Neurooncology Tuebingen @neurooncotue.bsky.social · 17/10/2025
@eanoassociation.bsky.social
021
Reposted by Neurooncology Tuebingen
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 17/10/2025
Just happening. Max Niyazi on stage at EANO 2025 👍🏼💡
172
Neurooncology Tuebingen @neurooncotue.bsky.social · 17/10/2025
Great comprehensive talk by @ghtabatabai.bsky.social to give insights into CRISPR screen. More to come! @eanoassociation.bsky.social
052
Reposted by Neurooncology Tuebingen
EANO @eanoassociation.bsky.social · 23/08/2025
🧠 Just published in Neuro-Oncology: A comprehensive consensus review by @neuroonc.bsky.social and EANO on current management and future directions in adult #Glioblastoma care. Explore key recommendations and research priorities. 🔗 academic.oup.com/neuro-oncolo... #NeuroOncology
1115
Reposted by Neurooncology Tuebingen
EANO @eanoassociation.bsky.social · 26/09/2025
🚨 At #EANO2025, we already expect more than 1,200 participants! Don’t miss out on this fantastic experience to meet experts in the field of #NeuroOncology from all over the world. Registration is still open eano.eu/eano2025/ We can’t wait to see you in #Prague!
083
Reposted by Neurooncology Tuebingen
EANO @eanoassociation.bsky.social · 24/09/2025
🧠 Recently published in Neuro-Oncology: EANS–EANO Guidelines on the Extent of Resection in Gliomas. We’re proud to share the outcome of collaborative effort by the joint task force of EANS and EANO, providing evidence-based recommendations for clinical practice. 🔗 academic.oup.com/neuro-oncolo...
02910
Neurooncology Tuebingen @neurooncotue.bsky.social · 29/09/2025
Innovative trial design, thank you for the opportunity for being part of it!
011
Neurooncology Tuebingen @neurooncotue.bsky.social · 29/09/2025
Extremely happy that we could have contributed!
011
Neurooncology Tuebingen @neurooncotue.bsky.social · 03/06/2025
Thank you for having the opportunity to present our data at this year DGNC in Hanover. #DGNC2025
041
Reposted by Neurooncology Tuebingen
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 20/04/2025
Almost 25 year old T-shirt, reminds me of great experience at MGH/HMS 2000/2001, @harvard.edu - hard to see this institution under pressure now, and impressed by the integrity and resilience of Harvard leadership (more on LinkedIn) 🙌 #Harvard #AcademicFreedom #ScienceForDemocracy #ScienceMatters
0113
Neurooncology Tuebingen @neurooncotue.bsky.social · 20/02/2025
Happy to represent Tuebingen in this initiative! #aufstehenfuerdemokratie
031
Reposted by Neurooncology Tuebingen
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 12/02/2025
Tübingen 12 Feb 2025 Geschwister Scholl Platz Democracy needs facts Science needs Democracy. #aufstehenfuerdemokratie
0125
Neurooncology Tuebingen @neurooncotue.bsky.social · 16/01/2025
We are more than happy that our publication "The Immunopeptidomic Landscape of Ependymomas Provides Actionable Antigens for T Cell-Based Immunotherapy" is accepted by Neurooncology Advances. academic.oup.com/noa/advance-... Check it out ;) @unituebingen.bsky.social @hih-tuebingen.bsky.social
academic.oup.com
The Immunopeptidomic Landscape of Ependymomas Provides Actionable Antigens for T Cell-Based Immunotherapy
AbstractBackground. Ependymoma are primary tumors of the nervous system. Due to their growth pattern, many ependymomas can be managed with neurosurgical re
073
Reposted by Neurooncology Tuebingen
Universität Tübingen @unituebingen.bsky.social · 13/01/2025
👍 Herzlich Willkommen auf dem Bluesky-Account der #unituebingen. Wir posten ab sofort hier und auf unseren anderen Kanälen, z.B. Instagram, Facebook, LinkedIn, Mastodon. Unsere Aktivitäten auf X haben wir beendet.
88814
Neurooncology Tuebingen @neurooncotue.bsky.social · 07/01/2025
Happy to see this finally out after a long team effort! 🎉🎉🎉 @hih-tuebingen.bsky.social @ghtabatabai.bsky.social
061
Reposted by Neurooncology Tuebingen
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 25/12/2024
Merry Christmas and very best wishes für 2025! @hih-tuebingen.bsky.social @unituebingen.bsky.social @neurooncotue.bsky.social
171
Reposted by Neurooncology Tuebingen
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 18/12/2024
New insights into #meningiomas, with The Brain Tumour Charity’s funding and led by @gelarehzadeh.bsky.social, has been included in their #Research Highlights of 2024. Read more about it here: www.thebraintumourcharity.org/news/researc...
Research highlights of 2024
041
Reposted by Neurooncology Tuebingen
Mathias Jucker @mathiasjucker.bsky.social · 16/12/2024
Two flagship chair professorships for neurodgenerative diseases in Tübingen, Germany. Both affiliated with our university @hih-tuebingen.bsky.social and the German Center for Neurodegenerative diseases @dzne.science. Apply and join us! www.nature.com/naturecareer... www.nature.com/naturecareer...
nature.com
Nature Careers | Science jobs | Choose from 1,225 live vacancies
Search for your next job from 1,225 live vacancies, or upload your CV now and let recruiters find you
01010
Reposted by Neurooncology Tuebingen
Hertie-Institut für klinische Hirnforschung (HIH) @hih-tuebingen.bsky.social · 17/12/2024
📢The Faculty of Medicine at the University of Tübingen invites applications for a position at the Hertie Center for Neurology for an Endowed #Professorship (W3) in #Neurology with a Focus on #Neurodegenerative #Diseases, available by 1 October 2026, potentially earlier Full PDF: tinyurl.com/y6bfky83
053
Reposted by Neurooncology Tuebingen
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 16/12/2024
@ghtabatabai is a neurologist and a physician scientist at the University of Tübingen and the Managing Director Neurology at the University Hospital Tübingen. Her research includes target discovery & validation, molecular mechanisms of treatment resistance, & novel delivery routes to brain tumors.
Member Spotlight: Dr. Ghazaleh Tabatabai
074
Reposted by Neurooncology Tuebingen
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 05/12/2024
Just happening in Tübingen: Great talk by Prof Ulrich Dirnagl on Research Integrity 🙌💡👍🏼 @hih-tuebingen.bsky.social
052
Neurooncology Tuebingen @neurooncotue.bsky.social · 15/12/2024
Great to see this finally out!
061
Reposted by Neurooncology Tuebingen
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 30/11/2024
Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lesoons ignored? academic.oup.com/neuro-oncolo...
academic.oup.com
Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored?
The treatment of patients with glioblastoma remains a challenge. Several large clinical trials of the last decades have failed and had—in retrospect—been b
084